A

Aspect Biosystems

Bioprints allogeneic tissue therapeutics

Senior Process Engineer

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
ContractVancouver, BC, Canada$124.7k - $131.7k /yrIn-person

About the Job

Requirements

  • A Master of Science or Ph.D. in Chemical Engineering, Bioengineering, Biomedical Engineering, or a related life science field, with 6–8 or more years of relevant industry experience in cell therapy, bioprocess development, or biologics manufacturing.
  • A hands-on background in developing, characterizing, and optimizing biomanufacturing processes; cell therapy experience is preferred.
  • Expertise in designing, implementing, and characterizing complex fluidic systems, including automated cell processing workflows such as washing, concentrating, and harvesting.
  • Ability to develop mathematical models and apply statistical methods, including Design of Experiments, for process characterization and defining Critical Process Parameters and Critical Quality Attributes.
  • Thorough knowledge of Good Manufacturing Practices and Good Documentation Practices.
  • Experience supporting technology transfer from Process Development to Manufacturing, including process qualification and validation activities such as sterilization and extractables and leachables.
  • Strong analytical, problem-solving, and data-driven decision-making skills.
  • Written and verbal communication skills, including the ability to present complex data and mentor junior team members.

Responsibilities

  • Lead the conceptualization, design, implementation, and characterization of complex fluidic systems, bioreactor scaling strategies, and automated cell processing workflows for washing, concentrating, and harvesting to reduce process risk and improve robustness.
  • Work with Process Development, Bioengineering, Engineering, and Manufacturing to integrate the cell therapy process into the final device platform, focusing on closed-system design and single-use technologies.
  • Lead process risk assessments, such as Failure Mode and Effects Analysis and Preliminary Hazard Analysis, for the cell manufacturing process and its interaction with the medical device component.
  • Develop mathematical models and implement approaches such as Design of Experiments to define Critical Process Parameters and Critical Quality Attributes.
  • Support technology transfer to Manufacturing, including process qualification and early-phase clinical manufacturing as needed.
  • Troubleshoot manufacturing processes and participate in out-of-specification and root cause analyses during manufacturing deviations or process improvements.
  • Work with Quality to define validation strategies for sterilization, biocompatibility, and extractables and leachables, and provide technical content for regulatory filings such as CTA and IND submissions.
  • Identify gaps in current cell therapy manufacturing and develop patentable technologies to improve yield, purity, and scalability.
  • Mentor others and foster technical excellence and rigorous data-driven decision-making.

Desired Qualifications

  • Experience with bioreactor systems and scaling strategies.
  • Familiarity with regulatory requirements for cell therapy products, including providing technical content for CTA and IND filings.
  • Direct experience operating within a medical-device Design Control framework, such as FDA 21 CFR Part 820, specifically for process inputs and outputs and risk management.

About the Company

Aspect Biosystems

Bioprints allogeneic tissue therapeutics

Aspect Biosystems develops bioprinted tissue therapeutics for regenerative medicine. Its work centers on a platform that combines proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design to create allogeneic tissue therapeutics for clinical use. The company works through strategic collaborations with leading pharmaceutical and biotechnology firms, funded by partnerships and investors. The product approach uses bioprinting to assemble tissue constructs layer by layer from cells and biomaterials, guided by computational design, producing off-the-shelf (allogeneic) tissue therapies. What sets the company apart is its integrated platform, a focus on allogeneic, scalable tissue products, and a collaboration-driven business model with strong industry partnerships, backed by a solid funding base. Its goal is to advance regenerative medicine by delivering a targeted pipeline of bioprinted tissue therapeutics through collaborations and continued investment.

Company size
51-200
Company stage
Grant
Total funding
$352.7M
Headquarters
Vancouver, Canada
Founded
2013

Recently Posted Jobs

Explore more opportunities at Aspect Biosystems

See more jobs